Sun, March 29, 2026
Sat, March 28, 2026

Medigap Access Crisis: Insurance Denials Surge, Sparking Congressional Action

Washington, D.C. - The accessibility of Medigap insurance plans is rapidly deteriorating, leaving a growing number of Medicare beneficiaries without crucial supplemental coverage. What began as a trickle of reported denials has swelled into a significant crisis, triggering a robust bipartisan response in Congress and igniting a national debate about fairness and access within the Medicare system. The core issue: insurance companies are increasingly rejecting applicants for Medigap plans based on stricter underwriting criteria, a trend that threatens to leave vulnerable seniors financially exposed.

The spike in denials - data from the Medicare Rights Center indicates a jump from approximately 5% in 2022 to over 15% in 2025 - isn't merely statistical. It represents real hardship for individuals who rely on Medigap plans to bridge the gaps in traditional Medicare coverage. While Medicare Part A covers hospitalization and Part B covers doctor visits, these parts often leave beneficiaries responsible for substantial out-of-pocket costs like deductibles, co-pays, and coinsurance. Medigap plans are designed to alleviate these financial burdens, and being denied access is causing considerable anxiety for many.

Representative Eleanor Vance (D-CA), a leading voice in the congressional investigation, minced no words during a recent hearing. "We are witnessing a concerning pattern of insurance companies prioritizing profits over people. Locking seniors out of essential healthcare coverage due to manageable health conditions is simply unconscionable." Vance is spearheading efforts to introduce legislation aimed at reining in insurance company practices and guaranteeing access to Medigap coverage.

Healthcare advocates echo these concerns. Maria Rodriguez of the National Council on Aging reports instances of applicants being denied coverage for conditions many would consider minor - controlled high blood pressure, a history of successfully treated depression, even temporary ailments. "The bar for acceptance seems to be continually rising, and it's disproportionately impacting those who need the coverage most," Rodriguez explains. "These aren't catastrophic illnesses; they're conditions that, with proper management, don't significantly impact overall health. To deny coverage based on these factors is both unfair and economically damaging."

The Centers for Medicare & Medicaid Services (CMS) acknowledges the rising denial rates, but their hands appear tied. Currently, CMS lacks direct regulatory authority over Medigap underwriting standards, leaving insurance companies significant latitude in their assessment of applicants. This lack of oversight is a key point of contention for congressional critics, who argue that it allows insurance companies to operate with impunity.

However, insurance industry representatives maintain that their stricter underwriting is a necessary measure to preserve the long-term viability of Medigap plans. They contend that relaxed standards would lead to "adverse selection"--a scenario where a disproportionate number of individuals with pre-existing conditions enroll, driving up premiums for all policyholders. "We need to ensure that Medigap plans remain financially sustainable," argues a spokesperson for the Health Insurance Association of America. "That requires responsible underwriting practices to balance the risk pool." This argument, however, is not sitting well with lawmakers who believe the industry is prioritizing financial stability at the expense of access for vulnerable populations.

Several legislative proposals are currently under consideration, reflecting the urgency of the situation. One proposal gaining traction would limit the ability of insurance companies to deny coverage based on pre-existing conditions, mirroring protections already in place under the Affordable Care Act for comprehensive health insurance. Another aims to establish guaranteed acceptance periods for Medigap plans, similar to the special enrollment periods available under Medicare Parts A and B. A third, more ambitious proposal seeks to expand CMS's oversight of the Medigap market, granting the agency the authority to regulate underwriting standards and ensure fair access to coverage.

The debate extends beyond simply guaranteeing access. Experts are also examining the role of standardized Medigap plans and whether further standardization could simplify the application process and reduce the potential for discriminatory underwriting. Furthermore, there's growing discussion around the need for increased transparency in the denial process, allowing applicants to understand exactly why their applications were rejected and what options they have for appealing the decision.

The coming months will be critical as Congress navigates these complex issues. The outcome of these deliberations will not only determine the future of Medicare supplemental insurance but also profoundly impact the financial security and healthcare access of millions of seniors across the nation. The stakes are high, and the pressure is mounting for a solution that balances the financial stability of the insurance industry with the fundamental right of all Medicare beneficiaries to affordable and comprehensive healthcare.


Read the Full Press-Telegram Article at:
[ https://www.presstelegram.com/2026/03/26/medicare-medigap-plan-refusals/ ]